These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23058346)

  • 21. Effects of intravenous nesiritide on pulmonary vascular hemodynamics in pulmonary hypertension.
    Michaels AD; Chatterjee K; De Marco T
    J Card Fail; 2005 Aug; 11(6):425-31. PubMed ID: 16105633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary hypertension in heart transplantation: discrepant prognostic impact of pre-operative compared with 1-year post-operative right heart hemodynamics.
    Gude E; Simonsen S; Geiran OR; Fiane AE; Gullestad L; Arora S; Relbo A; Andreassen AK
    J Heart Lung Transplant; 2010 Feb; 29(2):216-23. PubMed ID: 19837606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of pulmonary hypertension on early hemodynamics, morbidity and mortality after orthotopic heart transplantation. A single center study.
    Bedanova H; Orban M; Vrsansky D; Spinarova L; Hude P; Krejci J; Ondrasek J; Nemec P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Mar; 157(1):35-40. PubMed ID: 23073529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of beta-blocker therapy and outcomes in patients with pulmonary arterial hypertension.
    So PP; Davies RA; Chandy G; Stewart D; Beanlands RS; Haddad H; Pugliese C; Mielniczuk LM
    Am J Cardiol; 2012 May; 109(10):1504-9. PubMed ID: 22385756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of end-stage heart failure is predicted by long-term therapeutic response rather than initial hemodynamic and neurohormonal profile.
    Levine TB; Levine AB; Goldberg D; Narins B; Goldstein S; Lesch M
    J Heart Lung Transplant; 1996 Mar; 15(3):297-303. PubMed ID: 8777214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of sildenafil on survival of patients with idiopathic pulmonary arterial hypertension.
    Zeng WJ; Sun YJ; Gu Q; Xiong CM; Li JJ; He JG
    J Clin Pharmacol; 2012 Sep; 52(9):1357-64. PubMed ID: 21956607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
    Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
    Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sodium Nitroprusside in Patients With Mixed Pulmonary Hypertension and Left Heart Disease: Hemodynamic Predictors of Response and Prognostic Implications.
    Lim HS; Zaphiriou A
    J Card Fail; 2016 Feb; 22(2):117-24. PubMed ID: 26547011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?
    Liden H; Haraldsson A; Ricksten SE; Kjellman U; Wiklund L
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):1029-34; discussion 1034-5. PubMed ID: 19211259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term treatment, tolerability, and survival with sub-cutaneous treprostinil for severe pulmonary hypertension.
    Sadushi-Koliçi R; Skoro-Sajer N; Zimmer D; Bonderman D; Schemper M; Klepetko W; Glatz J; Jakowitsch J; Lang IM
    J Heart Lung Transplant; 2012 Jul; 31(7):735-43. PubMed ID: 22480725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure.
    Lewis GD; Lachmann J; Camuso J; Lepore JJ; Shin J; Martinovic ME; Systrom DM; Bloch KD; Semigran MJ
    Circulation; 2007 Jan; 115(1):59-66. PubMed ID: 17179022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphodiesterase 5 inhibition with sildenafil reverses exercise oscillatory breathing in chronic heart failure: a long-term cardiopulmonary exercise testing placebo-controlled study.
    Guazzi M; Vicenzi M; Arena R
    Eur J Heart Fail; 2012 Jan; 14(1):82-90. PubMed ID: 22067410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of pulmonary hemodynamic parameters in cardiac transplant candidates.
    Sobieszczańska-Małek M; Zieliński T; Piotrowski W; Korewicki J; Of Polkard-Hf OB
    Cardiol J; 2014; 21(5):532-8. PubMed ID: 24526510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac uses of phosphodiesterase-5 inhibitors.
    Schwartz BG; Levine LA; Comstock G; Stecher VJ; Kloner RA
    J Am Coll Cardiol; 2012 Jan; 59(1):9-15. PubMed ID: 22192662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-transplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation.
    Butler J; Stankewicz MA; Wu J; Chomsky DB; Howser RL; Khadim G; Davis SF; Pierson RN; Wilson JR
    J Heart Lung Transplant; 2005 Feb; 24(2):170-7. PubMed ID: 15701433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bosentan in heart transplantation candidates with severe pulmonary hypertension: efficacy, safety and outcome after transplantation.
    Perez-Villa F; Farrero M; Cardona M; Castel MA; Tatjer I; Penela D; Vallejos I
    Clin Transplant; 2013; 27(1):25-31. PubMed ID: 22861120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results].
    Jiménez López-Guarch C; Escribano Subias P; Tello de Meneses R; Delgado Jiménez JF; Sadia Pérez D; Velázquez Martín MT; Gómez Sánchez MA; Sáenz de la Calzada C
    Rev Esp Cardiol; 2004 Oct; 57(10):946-51. PubMed ID: 15469792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iloprost improves hemodynamics in patients with severe chronic cardiac failure and secondary pulmonary hypertension.
    Sablotzki A; Czeslick E; Schubert S; Friedrich I; Mühling J; Dehne MG; Grond S; Hentschel T
    Can J Anaesth; 2002 Dec; 49(10):1076-80. PubMed ID: 12477682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversal of secondary pulmonary hypertension by axial and pulsatile mechanical circulatory support.
    Torre-Amione G; Southard RE; Loebe MM; Youker KA; Bruckner B; Estep JD; Tierney M; Noon GP
    J Heart Lung Transplant; 2010 Feb; 29(2):195-200. PubMed ID: 19782604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: a phase IIb double-blind, randomized, placebo-controlled, dose-ranging hemodynamic study.
    Bonderman D; Ghio S; Felix SB; Ghofrani HA; Michelakis E; Mitrovic V; Oudiz RJ; Boateng F; Scalise AV; Roessig L; Semigran MJ;
    Circulation; 2013 Jul; 128(5):502-11. PubMed ID: 23775260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.